Moffitt Researchers Identify Pathway that Regulates Angiogenesis in Tumors

Signaling through the protein YAP1 controls angiogenesis under normal and low oxygen conditions

Moffitt Researchers Identify Splice Variant Biomarkers in Clear Cell Renal Cell Carcinoma

Survival risk tool based on expression of splice variants identifies patients at high risk of poor outcomes

Turnstone Biologics and Moffitt Cancer Center Announce Strategic Alliance to Advance Next-Generation TIL Therapies for Solid Tumors

Strategic alliance significantly expands ongoing multi-year collaboration by granting Turnstone broader access and enhanced benefits at Moffitt

Moffitt Study Shows Adaptive Therapy Improves Outcomes Reduces Care Costs for Prostate Cancer Patients

Using evolutionary principles and mathematical modeling to outline an intermittent therapy approach using abiraterone can save patients as much as...

Moffitt Researchers Determine 1st Crystal Structure of LAG3

The discovery reveals how the protein binds to ligands and inhibitory antibodies, and will improve cancer drug discovery

Moffitt Researchers Contribute to Discovery of Mechanism Leading to Drug Resistance in Prostate Cancer

Consecutive molecular modifications of the androgen receptor can contribute to drug resistance, which can be blocked with an ACK1 inhibitor

Moffitt Researchers Identify Tumor-Based Methylation Patterns as Cancer Biomarkers

These patterns predict the composition of the tumor immune environment and patient outcomes

Moffitt Cancer Center presents La Ciudad se Viste de Rosa May 21

The streaming event encourages Spanish speaking women to care for their own health

Moffitt Researchers Identify Pathway that Regulates Lipid Synthesis and Contributes to Tumor Survival

The alterations are associated with poor outcomes and disease progression

Moffitt Researchers Identify Key Factors Impacting Adaptive Therapy

Spatial organization and competition between drug-resistant cells affect treatment outcomes

Moffitt Researchers Discover New Target for CAR T Cells in Solid Tumors

Chimeric antigen receptor T cells that target OR2H1 inhibit lung and ovarian tumor growth in mice

Moffitt Researchers Develop Model to Predict Patients with Poor Lung Cancer Outcomes

The model uses radiomic features from screening images to inform lesions associated with very poor survival

AutoNation Returns for the 10th Year as the Presenting Sponsor for Miles for Moffitt

Registration now open for fundraising event Nov. 19 in downtown Tampa

Moffitt Researchers Identify Key Characteristics of Immune Cells in Ovarian Cancer

Tissue-resident memory T cells are important mediators of immune response

Moffitt Researchers Identify Immunosuppression as a Key Factor Leading to Colorectal Cancer Development

The team used mathematical modeling to characterize the interplay between immune suppression, immune blockade and antigenicity

News Releases